Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Operating Expenses (2018 - 2026)

Updated

Regenerative Medical Technology's Operating Expenses was $2.01 million in Q2 2026, up 140.7% from $835,919 a year earlier and up 30.9% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Operating Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regenerative Medical Technology's Operating Expenses was $5.58 million through Jun 30, 2026, up 87.8% year-over-year; for FY2025, it came in at $3.68 million, up 34.1% from FY2024.

  • Operating Expenses has now increased for three consecutive years, with a five-year compound annual growth rate of 51.6% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $2.74 million in FY2024 (+14.7%), $2.39 million in FY2023 (+16.0%), $2.06 million in FY2022 (-79.5%) and $10.07 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Operating Expenses since Q3 2021.
  • Compared with a year earlier, Operating Expenses has increased for 13 straight quarters, with growth averaging 52.3% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 428.3%); the worst was Q3 2022 (a decline of 95.3%).
  • Per Business Quant data, RMTG's Operating Expenses in the three quarters before Q2 2026 was $1.54 million (Q1 2026), $1.09 million (Q4 2025) and $947,318 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 2.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.01 Mn
Mar 31, 2026 1.54 Mn
Dec 31, 2025 1.09 Mn
Sep 30, 2025 947,318.00
Jun 30, 2025 835,919.00
Mar 31, 2025 808,934.00
Dec 31, 2024 599,565.00
Sep 30, 2024 727,413.00
Jun 30, 2024 740,865.00
Mar 31, 2024 674,096.00
Dec 31, 2023 569,861.00
Sep 30, 2023 525,356.00
Jun 30, 2023 684,665.00
Mar 31, 2023 611,012.00
Dec 31, 2022 474,002.00
Sep 30, 2022 426,578.00
Jun 30, 2022 512,592.00
Mar 31, 2022 648,654.00
Dec 31, 2021 576,618.00
Sep 30, 2021 9.09 Mn
API Access

Regenerative Medical Technology Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=RMTG&period=max&api_key=YOUR_API_KEY